RxDoctor Payments Data

Landon Johnson, MD

Dermatology · Wichita, KSNPI 1346478054

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.1% of the total across 290 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations.

$5,641in general payments, 2019–2025

Across 290 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$1K
  • E.r. Squibb & Sons, L.L.C.$608
  • Novartis$374
  • Lilly USA, LLC$359
  • Sanofi$329
  • plus $2K from 22 others

What the payments were for

  • Food & beverage$5,47997%
  • Education$1623%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,641 in reported general payments places this provider in the 80th percentile of 82 dermatology providers in Kansas.

See all dermatology providers in Kansas

Medicare billing

Part B allowed, 2024
$1,707,073
Medicare patients
1,921
Services billed
7,945

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Monohydrate158$2,823
Clobetasol Propionate42$1,253
Metronidazole11$679
Triamcinolone Acetonide107$636
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc60$614
Ketoconazole49$535
Fluconazole40$451
Clindamycin Phosphate18$447
Cephalexin255$401
Imiquimod17$373
Hydroxychloroquine Sulfate20$296
ValacyclovirValacyclovir Hcl70$258
Minoxidil17$236
Doxycycline Hyclate11$179
Mupirocin16$135

Paid to pharmacies, not to this prescriber.

Other dermatology in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →